This Pharmaceutical Giant Just Poured $11B — Time to Buy?
A major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Discover practical steps to improve your budget management skills with simple habits and tracking methods. This intro covers baselines, goals, and steady progress.
22,388 articlesA major pharma player just spent roughly $11 billion to acquire a biotech with a promising eczema drug. This article ...
Cloudflare signals a bold pivot to AI-enabled edge infrastructure, reorganizing around AI and cutting roughly one-fif...
Dream Finders’ bid for Beazer has evolved into a live governance case, testing board discretion against shareholder r...
A Fulton Financial director sold shares after the stock surged about 26%. This article breaks down what insider sales...
Chubb sits as a stalwart in global insurance, trading at roughly 12x earnings. This article breaks down what that mea...
Institutional moves can illuminate a stock's future. This article unpacks what it means when an investment manager be...
A high-conviction AI bet is reshaping how Ackman runs his hedge fund. Learn why nearly 40% of his capital sits in thr...
Step Finance and two affiliate Solana projects are ending operations after a wallet compromise drained millions. The ...
B&G Foods is in the spotlight as its stock roars higher. This article explains the mix of quarterly results, strategi...
A compact team aims to redefine payments by moving crypto cards onto an Ethereum layer-2. This deep dive explains how...
Investors watched iperionx limited stock crashed today after weak half-year results. This in-depth look breaks down t...
Brady Corporation, Pitney Bowes, and CompoSecure report stronger cash flow, expanding margins, and strategic bets in ...